BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 14681206)

  • 1. SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase.
    Jin J; Shirogane T; Xu L; Nalepa G; Qin J; Elledge SJ; Harper JW
    Genes Dev; 2003 Dec; 17(24):3062-74. PubMed ID: 14681206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential roles for checkpoint kinases in DNA damage-dependent degradation of the Cdc25A protein phosphatase.
    Jin J; Ang XL; Ye X; Livingstone M; Harper JW
    J Biol Chem; 2008 Jul; 283(28):19322-8. PubMed ID: 18480045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage.
    Busino L; Donzelli M; Chiesa M; Guardavaccaro D; Ganoth D; Dorrello NV; Hershko A; Pagano M; Draetta GF
    Nature; 2003 Nov; 426(6962):87-91. PubMed ID: 14603323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual regulation of Cdc25A by Chk1 and p53-ATF3 in DNA replication checkpoint control.
    Demidova AR; Aau MY; Zhuang L; Yu Q
    J Biol Chem; 2009 Feb; 284(7):4132-9. PubMed ID: 19060337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cyclin-dependent kinase 2 by the Chk1-Cdc25A pathway during the S-phase checkpoint activated by fludarabine: dysregulation by 7-hydroxystaurosporine.
    Sampath D; Shi Z; Plunkett W
    Mol Pharmacol; 2002 Sep; 62(3):680-8. PubMed ID: 12181445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The extracellular signal-regulated kinase-mitogen-activated protein kinase pathway phosphorylates and targets Cdc25A for SCF beta-TrCP-dependent degradation for cell cycle arrest.
    Isoda M; Kanemori Y; Nakajo N; Uchida S; Yamashita K; Ueno H; Sagata N
    Mol Biol Cell; 2009 Apr; 20(8):2186-95. PubMed ID: 19244340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid destruction of human Cdc25A in response to DNA damage.
    Mailand N; Falck J; Lukas C; Syljuâsen RG; Welcker M; Bartek J; Lukas J
    Science; 2000 May; 288(5470):1425-9. PubMed ID: 10827953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation at serine 75 is required for UV-mediated degradation of human Cdc25A phosphatase at the S-phase checkpoint.
    Hassepass I; Voit R; Hoffmann I
    J Biol Chem; 2003 Aug; 278(32):29824-9. PubMed ID: 12759351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-TrCP recognizes a previously undescribed nonphosphorylated destruction motif in Cdc25A and Cdc25B phosphatases.
    Kanemori Y; Uto K; Sagata N
    Proc Natl Acad Sci U S A; 2005 May; 102(18):6279-84. PubMed ID: 15845771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA damage-induced degradation of Cdc25A does not lead to inhibition of Cdk2 activity in mouse embryonic stem cells.
    Koledova Z; Kafkova LR; Krämer A; Divoky V
    Stem Cells; 2010 Mar; 28(3):450-61. PubMed ID: 20104581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints.
    Zhao H; Watkins JL; Piwnica-Worms H
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14795-800. PubMed ID: 12399544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulatory beta-subunit of protein kinase CK2 accelerates the degradation of CDC25A phosphatase through the checkpoint kinase Chk1.
    Kreutzer J; Guerra B
    Int J Oncol; 2007 Nov; 31(5):1251-9. PubMed ID: 17912454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis.
    Falck J; Mailand N; Syljuåsen RG; Bartek J; Lukas J
    Nature; 2001 Apr; 410(6830):842-7. PubMed ID: 11298456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP.
    Watanabe N; Arai H; Nishihara Y; Taniguchi M; Watanabe N; Hunter T; Osada H
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4419-24. PubMed ID: 15070733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATR, Claspin and the Rad9-Rad1-Hus1 complex regulate Chk1 and Cdc25A in the absence of DNA damage.
    Sørensen CS; Syljuåsen RG; Lukas J; Bartek J
    Cell Cycle; 2004 Jul; 3(7):941-5. PubMed ID: 15190204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A.
    Sørensen CS; Syljuåsen RG; Falck J; Schroeder T; Rönnstrand L; Khanna KK; Zhou BB; Bartek J; Lukas J
    Cancer Cell; 2003 Mar; 3(3):247-58. PubMed ID: 12676583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells.
    Tyagi A; Singh RP; Agarwal C; Siriwardana S; Sclafani RA; Agarwal R
    Carcinogenesis; 2005 Nov; 26(11):1978-87. PubMed ID: 15975956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CK1ε targets Cdc25A for ubiquitin-mediated proteolysis under normal conditions and in response to checkpoint activation.
    Piao S; Lee SJ; Xu Y; Gwak J; Oh S; Park BJ; Ha NC
    Cell Cycle; 2011 Feb; 10(3):531-7. PubMed ID: 21252624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanism.
    Uto K; Inoue D; Shimuta K; Nakajo N; Sagata N
    EMBO J; 2004 Aug; 23(16):3386-96. PubMed ID: 15272308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents.
    Xiao Z; Chen Z; Gunasekera AH; Sowin TJ; Rosenberg SH; Fesik S; Zhang H
    J Biol Chem; 2003 Jun; 278(24):21767-73. PubMed ID: 12676925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.